Actelion drug setback unlikely to derail J&J talks: analysts | International News Live Blog

https://internationalnewsliveblog.wordpress.com/2017/01/23/actelion-drug-setback-unlikely-to-derail-jj-talks-analysts/

ZURICH (Reuters) – A blow to Actelion’s Opsumit drug in a test is unlikely to have an impact on talks over a strategic deal with Johnson & Johnson , analysts said on Monday, as the Swiss drugmaker’s shares shook off the news. http://internationalnewslive.com/actelion-drug-setback-unlikely-to-derail-jj-talks-analysts/